Showing results (211-220 of 316) with videos related to

Sort By:
Pageof 32
Gastroenterology|August 8, 2006
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatmentJosé M Sánchez-Tapias, Moisés Diago, Pedro Escartín, et al.
Adicciones|October 6, 2022
Certification program of Addiction Centres for hepatitis C virus elimination in Spain. HepCelentes ProjectJoan Colom, Marta Torrens, Ángeles Rodríguez-Cejas, et al.
Hepatology Communications|March 28, 2022
Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipientsAntonio Cuadrado, María Del Barrio, José Ignacio Fortea, et al.
Immunity & Ageing : I & A|November 18, 2023
Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health riskRubén Martín-Escolano, Erick Joan Vidal-Alcántara, Javier Crespo, et al.
Scientific Reports|May 11, 2021
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at homePaula Iruzubieta, Tatiana Fernández-Lanas, Laura Rasines, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2022
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histologyJosé L Calleja, Jesús Rivera-Esteban, Rocío Aller, et al.
Cells|December 23, 2022
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and AmidationMarta Alonso-Peña, Ricardo Espinosa-Escudero, Heike M Hermanns, et al.
Journal of Hepatology|July 6, 2024
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver diseaseDavid Marti-Aguado, José Luis Calleja, Eduardo Vilar-Gomez, et al.
The American Journal of Gastroenterology|June 28, 2018
Microenvironment Eradication of Hepatitis C: A Novel Treatment ParadigmAntonio Cuadrado, Susana Llerena, Carmen Cobo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 28, 2018
Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humansMarta Cruces-Sande, Rocío Vila-Bedmar, Alba C Arcones, et al.
Pageof 32